A New Charge for Public Health: Prevention of SARS-CoV-2 Vaccine Politicization

by Toby D. Terwilliger, MD As several promising SARS-CoV-2 vaccines enter into Phase II and III clinical trials, it is incumbent on physicians and public health officials to keep the public informed regarding the requisite process of vaccine development. It is eminently imaginable that we may find ourselves in a situation where certain politicians pressure the FDA, pharmaceutical companies, and
Read more